S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis

Journal of Neuroimmune Pharmacology

Volumn 5, Issue 2, 2010, Pages 240-251

  Nath, Narender ^a   Morinaga, Osamu ^b   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Autoimmunity; EAE; GSNO; IL 17; Inflammation; MS; ROR gamma; STAT; T bet; Tcells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE; PROTEOLIPID PROTEIN; S NITROSOGLUTATHIONE; STAT3 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR ROR GAMMA; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MODULATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GATA3 TRANSCRIPTION FACTOR; GLYCOPROTEINS; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; MYELIN PROTEOLIPID PROTEIN; NITRIC OXIDE DONORS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PEPTIDE FRAGMENTS; PHOSPHORYLATION; S-NITROSOGLUTATHIONE; SPINAL CORD; STAT TRANSCRIPTION FACTORS; TH1 CELLS; TH2 CELLS;

EID: 77954563433     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-009-9187-x     Document Type: Article

References (71)

1. Allione A, Bernabei P, Bosticardo M, Ariotti S, Forni G, Novelli F (1999) Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. J Immunol 163:4182-4191
2. Bauer H, Jung T, Tsikas D, Stichtenoth DO, Frolich JC, Neumann C (1997) Nitric oxide inhibits the secretion of T-helper 1- and Thelper 2-associated cytokines in activated human T cells. Immunology 90:205-211
3. Becher B, Bechmann I, Greter M (2006) Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 84:532-543
4. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238
5. Bogdan C (1998) The multiplex function of nitric oxide in (auto)immunity. J Exp Med 187:1361-1365
6. Bogdan C (2001a) Nitric oxide and the immune response. Nat Immunol 2:907916
7. Bogdan C (2001b) Nitric oxide and the regulation of gene expression. Trends Cell Biol 11:66-75
8. Chitnis T, Khoury SJ (2003) Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol Res 28:223-239
9. Chiueh CC (1999) Neuroprotective properties of nitric oxide. Ann N Y Acad Sci 890:301-311
10. Chiueh CC, Rauhala P (1999) The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic Res 31:641-650
11. Cirino G, Fiorucci S, Sessa WC (2003) Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol Sci 24:91-95
12. Dalton DK, Wittmer S (2005) Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1- mediated autoimmunity: evidence from EAE in iNOS KO mice. J Neuroimmunol 160:110-121
13. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S (2000) Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 192:117-122
14. Diefenbach A, Schindler H, Rollinghoff M, Yokoyama WM, Bogdan C (1999) Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 284:951-955
15. Dong C (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8:337-348
16. Fenyk-Melody JE, Garrison AE, Brunnert SR, Weidner JR, Shen F, Shelton BA, Mudgett JS (1998) Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J Immunol 160:2940-2946
17. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG (1996) Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156:5-7
18. Fortenberry JD, Owens ML, Chen NX, Brown LA (2001) Snitrosoglutathione inhibits TNF-alpha-induced NFkappaB activation in neutrophils. Inflamm Res 50:89-95
19. Foster MW, McMahon TJ, Stamler JS (2003) S-nitrosylation in health and disease. Trends Mol Med 9:160-168
20. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132
21. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, Housseau F, Yu H, Pardoll DM, Drake CG (2007) Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 179:4313-4317
22. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD (2005) Macrophages and neurodegeneration. Brain Res Brain Res Rev 48:185-195
23. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS (2005) Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6:150-166
24. Hoey S, Grabowski PS, Ralston SH, Forrester JV, Liversidge J (1997) Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gammadependent mechanism. J Immunol 159:5132-5142
25. Hogg N (1999) The kinetics of S-transnitrosation-a reversible second-order reaction. Anal Biochem 272:257-262
26. Hogg N (2000) Biological chemistry and clinical potential of Snitrosothiols. Free Radic Biol Med 28:1478-1486
27. Hogg N (2002) The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol 42:585-600
28. Imitola J, Chitnis T, Khoury SJ (2005) Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther 106:163-177
29. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121-1133
30. Izikson L, Klein RS, Luster AD, Weiner HL (2002) Targeting monocyte recruitment in CNS autoimmune disease. Clin Immunol 103:125-131
31. Jourdheuil D, Jourdheuil FL, Feelisch M (2003) Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide. Evidence for a free radical mechanism. J Biol Chem 278:15720-15726
32. Kahl KG, Schmidt HH, Jung S, Sherman P, Toyka KV, Zielasek J (2004) Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neurosci Lett 358:58-62
33. Khan M, Sekhon B, Giri S, Jatana M, Gilg AG, Ayasolla K, Elango C, Singh AK, Singh I (2005) S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab 25:177-192
34. Khan M, Jatana M, Elango C, Paintlia AS, Singh AK, Singh I (2006) Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 15:114-124
35. Kluge I, Gutteck-Amsler U, Zollinger M, Do KQ (1997) Snitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry. J Neurochem 69:2599-2607
36. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-573
37. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM (2008) IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 205:1535-1541
38. Lander HM, Sehajpal P, Levine DM, Novogrodsky A (1993) Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 150:1509-1516
39. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL- 23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233-240
40. Li H, Forstermann U (2000) Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244-254
41. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632
42. Mangan PR, Harrington LE, OQuinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT (2006) Transforming growth factor-beta induces development of the T (H)17 lineage. Nature 441:231-234
43. Martinez-Ruiz A, Lamas S (2004) S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 62:43-52
44. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM (1993) Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178:749-754
45. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ (2007) TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8:1390-1397
46. Megson IL (2000) Nitric oxide donor drugs. Drugs Future 25:701-715
47. Mohr S, Zech B, Lapetina EG, Brune B (1997) Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun 238:387-391
48. Moilanen E, Vapaatalo H (1995) Nitric oxide in inflammation and immune response. Ann Med 27:359-367
49. Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2:933-944
50. Nath N, Prasad R, Giri S, Singh AK, Singh I (2006) T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology 118:384-391
51. Niedbala W, Wei XQ, Piedrafita D, Xu D, Liew FY (1999) Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol 29:2498-2505
52. Pannu R, Singh I (2006) Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem Int 49:170-182
53. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133-1141
54. Prasad R, Giri S, Nath N, Singh I, Singh AK (2006) GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Glia 55:65-77
55. Rauhala P, Lin AM, Chiueh CC (1998) Neuroprotection by Snitrosoglutathione of brain dopamine neurons from oxidative stress. Faseb J 12:165-173
56. Schrammel A, Gorren AC, Schmidt K, Pfeiffer S, Mayer B (2003) Snitrosation of glutathione by nitric oxide, peroxynitrite, and (*) NO/O(2)(*-). Free Radic Biol Med 34:1078-1088
57. Segal BM (2003) Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Curr Allergy Asthma Rep 3:86-93
58. Shi FD, Flodstrom M, Kim SH, Pakala S, Cleary M, Ljunggren HG, Sarvetnick N (2001) Control of the autoimmune response by type 2 nitric oxide synthase. J Immunol 167:3000-3006
59. Singh SP, Wishnok JS, Keshive M, Deen WM, Tannenbaum SR (1996) The chemistry of the S-nitrosoglutathione/glutathione system. Proc Natl Acad Sci USA 93:14428-14433
60. Skundric DS (2005) Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective. Curr Neurovasc Res 2:349-362
61. Sredni-Kenigsbuch D (2002) TH1/TH2 cytokines in the central nervous system. Int J Neurosci 112:665-703
62. Stamler JS (1994) Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936
63. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, Caspi RR (1999) Interleukin 12 protects from a T helper type 1- mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med 189:219-230
64. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Garside P, Padron J, Phillips RS (1994) Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 24:980-984
65. van der Veen RC (2001) Nitric oxide and T helper cell immunity. Int Immunopharmacol 1:1491-1500
66. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gilkeson GS (1994) The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 179:651-660
67. Williams MS, Noguchi S, Henkart PA, Osawa Y (1998) Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol 161:6526-6531
68. Wink DA, Darbyshire JF, Nims RW, Saavedra JE, Ford PC (1993) Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. Chem Res Toxicol 6:23-27
69. Wink DA, Nims RW, Darbyshire JF, Christodoulou D, Hanbauer I, Cox GW, Laval F, Laval J, Cook JA, Krishna MC et al (1994) Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/ O2 reaction. Chem Res Toxicol 7:519-525
70. Wynn TA (2005) T(H)-17: a giant step from T(H)1 and T(H)2. Nat Immunol 6:1069-1070
71. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282:9358-9363